Drugs / nidanib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07141810 Comparator | Oct 2025 → Apr 2028 expected | interstitial lung disease | Shanghai Pulmonary Hospital, Shanghai, China | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nidanib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07141810 ↗ |